West Pharmaceutical Services Inc
Suletud
SektorTervishoid
327.95 -0.74
Ülevaade
Aktsiahinna muutus
24h
Min
326.77
Max
329.25
Sissetulek | 6.7M 139M |
|---|---|
Müük | 40M 845M |
P/E Sektori keskmine | 42.017 49.052 |
Aktsiakasum | 2.13 |
Dividenditootlus | 0.27 |
Kasumimarginaal | 16.428 |
Töötajad | 10,800 |
EBITDA | -36M 174M |
Soovitused | Tugev "osta" hinnang |
|---|---|
12 kuu keskmine prognoos | +13.44% upside |
Dividenditootlus Sektori keskmine | 0.27% 2.36% |
|---|---|
Järgmine tulemuste avaldamine | 23. juuli 2026 |
Järgmine dividendimakse kuupäev | 5. aug 2026 |
Järgmine aktsia dividendi kuupäev (ex-date) | 29. juuli 2026 |
Turukapital | 2.6B 23B |
|---|---|
Eelmine avamishind | 328.69 |
Eelmine sulgemishind | 327.95 |
Uudiste sentiment
By Acuity
50%
50%
146 / 342 Pingereas Healthcare
West Pharmaceutical Services Inc Graafik
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
Ettevõttest West Pharmaceutical Services Inc
West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.